Atherton, CA, United States of America

Larisa Tsavaler


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Larisa Tsavaler: Innovator in Prostate Cancer Detection

Introduction

Larisa Tsavaler is a prominent inventor based in Atherton, California. She has made significant contributions to the field of cancer detection, particularly focusing on prostate tumors. Her innovative work has led to the development of novel compositions that aid in the diagnosis and treatment of prostate cancer.

Latest Patents

Larisa Tsavaler holds 1 patent for her invention titled "Prostate tumor polynucleotide compositions and methods of detection thereof." This patent is directed towards novel polynucleotides and the polypeptides encoded by them, which are specific to human prostate tumor cells. The invention also includes chimeric polypeptide molecules that comprise the polypeptides fused to heterologous polypeptide sequences, along with antibodies that bind to these polypeptides. Furthermore, the patent outlines methods for producing the polypeptides and detection assays that identify the presence of tumor cells in tissue or bodily fluid samples.

Career Highlights

Larisa has had a notable career, working with Dendreon Corporation, where she has been able to apply her expertise in biotechnology and cancer research. Her work has been instrumental in advancing the understanding of prostate cancer and improving diagnostic methods.

Collaborations

Throughout her career, Larisa has collaborated with esteemed colleagues, including Reiner Laus and Michael H Shapero. These collaborations have further enhanced her research and contributed to the development of innovative solutions in cancer detection.

Conclusion

Larisa Tsavaler's contributions to the field of prostate cancer detection exemplify her dedication to innovation and research. Her patented work continues to impact the medical community and offers hope for improved diagnostic and treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…